NCT00335920View on ClinicalTrials.gov

Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss

PHASE3CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2007

Conditions
Sudden Deafness
Interventions
DRUG

Dexamethasone-dihydrogenphosphate (4mg/ml)

Trial Locations (3)

72076

Department of Otorhinolaryngology, University of Tubingen, Tübingen

76042

St. Vincentius Kliniken, Klinik für HNO Heilkunde, Karlsruhe

89081

Bundeswehrkrankenhaus Ulm, Ulm

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT00335920 - Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss | Biotech Hunter | Biotech Hunter